The 3 most recent market catalysts affecting $KYN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 17, 2026
Corporate Catalyst
Bearish
Impact 85
Kyntra Bio Reports Third Quarter 2026 Financial Results and Terminates FG-3246 Phase 2 Trial
Kyntra Bio announced third-quarter 2026 net income of $0.2 million, a significant improvement from a $13.1 million net loss year-over-year, and extended its cash runway into 2028. …
Aug 13, 2026
Corporate Catalyst
Neutral
Impact 75
Kyntra Bio Q2 EPS $2.96, Sales $(1.474M) Miss $2.007M Estimate
This headline presents a mixed bag for Kyntra Bio. The strong EPS beat suggests efficient operations or one-time gains, which is positive for profitability. However, the significan…
Aug 4, 2026
Corporate Catalyst
Neutral
Impact 55
Reported Earlier, Kayne Anderson Energy Infrastructure Fund Reports $2.8B Net Assets, $16.49 Net Asset Value Per Share As Of July 31, 2026
The headline reports the net assets and NAV per share for the Kayne Anderson Energy Infrastructure Fund (KYN). This is a standard financial disclosure for a closed-end fund and pro…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.